Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Reata Pharma (RETA)
Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Is Biogen Stock a Buy Now? Motley Fool - Thu Sep 28, 9:07AM CDT

It has been one of the most talked about biotechs in recent years, but that's not enough to make its shares a buy.

BIIB : 249.59 (-1.29%)
RETA : 172.36 (+0.02%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, TRHC, VRTV, CTG PR Newswire - Tue Sep 12, 5:46PM CDT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RETA : 172.36 (+0.02%)
TRHC : 10.36 (-0.10%)
VRTV : 168.95 (+0.02%)
CTG : 10.38 (-0.05%)
3 Biotech Gainers to Consider stocknews.com - Mon Sep 11, 12:47PM CDT

Robust demand, technological advancements, government and private investment, are fueling the biotech industry’s expansion and driving game-changing therapies and product development. With the industry...

BIIB : 249.59 (-1.29%)
REGN : 804.36 (-1.67%)
RETA : 172.36 (+0.02%)
Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy? Motley Fool - Sat Sep 9, 6:45AM CDT

Buying a biotech is a good move, but it might not be enough to entice investors.

BIIB : 249.59 (-1.29%)
RETA : 172.36 (+0.02%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOVO, NEWR, RETA, AMNB PR Newswire - Tue Sep 5, 10:59PM CDT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SOVO : 22.47 (-0.13%)
NEWR : 85.96 (+0.01%)
RETA : 172.36 (+0.02%)
AMNB : 37.01 (-1.20%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCF, SCU, AMNB, RETA PR Newswire - Tue Aug 29, 7:21AM CDT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CCF : 127.13 (-0.05%)
SCU : 12.13 (+6.59%)
AMNB : 37.01 (-1.20%)
RETA : 172.36 (+0.02%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CELL, AEL, RETA PR Newswire - Mon Aug 21, 2:30PM CDT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CELL : 1.0000 (+0.31%)
AEL : 53.21 (-0.06%)
RETA : 172.36 (+0.02%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, NEWR, RETA, SOVO PR Newswire - Tue Aug 15, 5:15AM CDT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMNB : 37.01 (-1.20%)
NEWR : 85.96 (+0.01%)
RETA : 172.36 (+0.02%)
SOVO : 22.47 (-0.13%)
Housing, Retail Figures Due Next Week Baystreet - Fri Aug 11, 2:21PM CDT

Housing, Retail Figures Due Next Week Monday U.S. Featured Earnings Roivant (NASDAQ: ...

ROIV : 10.05 (-4.47%)
MNDY : 155.51 (-3.40%)
RETA : 172.36 (+0.02%)
HD : 292.43 (-2.47%)
A : 110.90 (-0.02%)
SE : 43.00 (-2.16%)
CSCO : 53.64 (-1.38%)
TJX : 87.90 (-0.88%)
SNPS : 453.97 (-2.12%)
WMT : 159.57 (-0.33%)
AMAT : 137.57 (-1.39%)
DE : 372.11 (-0.46%)
With an Acquisition on the Way, Is Biogen Stock a Buy? Motley Fool - Wed Aug 9, 7:30AM CDT

Can the biotech finally get back in the good graces of investors?

RETA : 172.36 (+0.02%)
BIIB : 249.59 (-1.29%)

Barchart Exclusives

Johnson & Johnson Stock Looks Like Good Value Now Barchart - 34 minutes ago
Johnson & Johnson stock (JNJ) recently spun off its consumer Kenvue business, which trades separately under the symbol KVUE. However, JNJ stock has dipped and now looks like good value. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot